Looking Into Biopharma IP Protection In China

Life Science Leader  Sept. 5, 2013

China is an attractive pharmaceutical market, but…“Companies need to have good internal procedures in place to keep trade secrets confidential, and need to be able to show that they have taken reasonable precautions,” says Benjamin Liu, assistant professor, Chinese Intellectual Property Resource Center, The John Marshall Law School, U.S.

Read more

Cookie Settings